Exodus Point Capital Management, LP T2 Biosystems, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.46 - $0.94 $23,506 - $48,034	-51,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.86 - $1.21 $11,252 - $15,831	13,084 Added 34.42%	51,100 $47,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $175,021 - $284,410	-168,290 Reduced 81.57%	38,016 $45,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $166,723 - $478,699	126,306 Added 157.88%	206,306 $334,000
Q4 2020 Feb 16, 2021	BUY	$1.06 - $1.51 $84,800 - $120,800	80,000 New	80,000 $99,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $34.8M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.